SAGITTA BIOTECH
About
Sagitta Biotech is developing innovative therapies against infectious diseases and cancer based on its viral vector/mRNA platform.
The technology allows us to develop very quickly vaccines that are safe and effective, but also to manufacture them at a very low cost (cents per dose) thanks to a "constant manufacturing process" (identical for all vaccines).
This allows us to get significant shortcuts during development, and reduce the cost of operations for our customers.
MANUFACTURING AND PRODUCTION
Bioprocessing and biomanufacturingVaccine manufacturing
THERAPEUTIC AREAS
ImmunologyInfectious diseasesOncology
CLINICAL DEVELOPMENT AND TRIALS
Infectious diseasesOncology
RESEARCH AND DEVELOPMENT
Vaccine developmentVaccine delivery systemsVaccine platformsViral vectors